CD4+ lymphocyte function with early human immunodeficiency virus infection.
about
Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNAHuman immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathwayCofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot studyChemokine coreceptor signaling in HIV-1 infection and pathogenesis.Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4.Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerizationPriming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein.Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus diseaseCD8+ cell anti-HIV activity correlates with the clinical state of the infected individualApoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2Human immunodeficiency virus Tat induces functional unresponsiveness in T cells.Performance Evaluation of the Becton Dickinson FACSPresto™ Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa.HIV-1 infection impairs cell cycle progression of CD4(+) T cells without affecting early activation responses.Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donorsTemporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expressionRole of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease.Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.Immunology of HIV infection.Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.The co-receptor signaling model of HIV-1 pathogenesis in peripheral CD4 T cellsHuman immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro.Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.Performance verification of the new fully automated Aquios flow cytometer PanLeucogate (PLG) platform for CD4-T-lymphocyte enumeration in South Africa.
P2860
Q24558732-89D5EEE0-A754-49D9-A561-A095804D4494Q24619935-2700F60C-59B4-44AB-80BE-D64A2D2164BEQ24645950-0C4A703C-FF94-4E4E-BD45-FF7A7393CE97Q33521304-4253D5F4-3264-417C-A82E-6BF7465E825AQ33656997-AC9FC2D0-253E-4333-9865-33D3F2F00099Q33675700-47FFF203-B2FE-4687-B100-07237FB560DFQ33739043-CEF96986-275F-4B4D-8A0F-02841526FD75Q33847162-9EE6FCEC-A18E-4083-AC04-E05BDB02577BQ34185306-0D704221-CB0F-4939-92ED-F03C0AB96FF6Q34188750-F311F769-B94F-40F9-AB08-202AF6ACB207Q34230284-A97DEF3B-4CA8-43BB-AC2B-74D15A71A5BFQ34323971-F690478C-EC6D-4425-A3A5-E18727F2F47FQ35325810-E0186E9F-3206-4BC3-8045-89CDEBEB5585Q35603192-4C1A6F85-E34F-4C07-A782-4B099F67BE96Q35830177-F5435B77-33D1-437E-A713-C78A73EFEFE1Q36029182-19C07182-C4DF-4DA6-998C-B4AC254D4D58Q36167859-4CAB2EA0-59E9-4051-9593-935AB4D5F71EQ36689807-5B5EAD14-DF06-4763-983A-363B75BAE37EQ36830303-F4E546ED-821D-4C9D-941D-921F12E6AE50Q37336150-9CBBCC00-03A2-487F-BCD3-3EE06AF8AB0AQ37365738-93EF9E22-2FF1-48C9-B78A-B3B8E7226AAAQ37371248-DF6D9235-9C23-4584-B80B-4C908EE21749Q37615905-AFEBFF90-410E-4670-B402-6A02ABAD757CQ40056665-22BB4303-B058-4D46-82F8-A66DDC132E5DQ41975845-99D67CBD-9012-46B7-9DCB-B9D5E7EA44ACQ43920738-6B370A2D-1AF7-4B3A-BBBC-03C493D656ECQ45163241-274C9C73-3DCE-4EFD-9FB3-A175ECAFFCA6Q47136337-313CE847-67B2-4B42-B069-45AD350CA1CE
P2860
CD4+ lymphocyte function with early human immunodeficiency virus infection.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մարտին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
name
CD4+ lymphocyte function with early human immunodeficiency virus infection.
@ast
CD4+ lymphocyte function with early human immunodeficiency virus infection.
@en
type
label
CD4+ lymphocyte function with early human immunodeficiency virus infection.
@ast
CD4+ lymphocyte function with early human immunodeficiency virus infection.
@en
prefLabel
CD4+ lymphocyte function with early human immunodeficiency virus infection.
@ast
CD4+ lymphocyte function with early human immunodeficiency virus infection.
@en
P2093
P2860
P356
P1476
CD4+ lymphocyte function with early human immunodeficiency virus infection.
@en
P2093
J E Groopman
K Anderson
R J Gurley
P2860
P304
P356
10.1073/PNAS.86.6.1993
P407
P577
1989-03-01T00:00:00Z